Skip to main content
Premium Trial:

Request an Annual Quote

IDT Alt-R CRISPR/Cas9 System

Integrated DNA Technologies has introduced the Alt-R CRISPR/Cas9 System for genome editing. The system provides ready-to-use RNA reagents that also reduce cell toxicity by featuring shortened, synthetic RNA oligonucleotides which do not activate innate cellular immune responses. The technology is based on the CRISPR/Cas9 system in Streptococcus pyogenes.